Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 2, 2002, Pages 103-110

  Wollina, U ^a,b   Graefe, T ^b   Feldrappe, S ^b   Andre S ^c   Wasano, K ^d   Kaltner, H ^c   Zick, Y ^e   Gabius, H J ^c  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d KYUSHU UNIVERSITY   (Japan)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Cutaneous T cell lymphoma; Galectin; Glycohistochemistry; Liposomal doxorubicin

Indexed keywords

CROSS REACTING ANTIBODY; DOXORUBICIN; GALECTIN; GALECTIN 1; GALECTIN 3; GALECTIN 4; GALECTIN 8; INTEGRIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE CLONE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SKIN LYMPHOMA; T LYMPHOCYTE;

AGED; ANTIBODIES; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL ADHESION; CELL DIVISION; DOXORUBICIN; FEMALE; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMAGGLUTININS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LIPOSOMES; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; PEPTIDE MAPPING; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036160228     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-001-0304-3     Document Type: Article

References (62)

1. Carbohydrate-binding protein 35: Properties of recombinant polypeptide and the individuality of the domains
2. Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
3. Galectins-1 and -3 and their ligands in tumor biology
4. Wedge-like glycodendrimers as inhibitors of binding of mammalian galectins to various glycoproteins, lactose maxiclusters and tumor or blood cell surface glycoconjugates
5. Expression of endogenous receptors for neoglycoproteins, especially lectins, which allow fiber typing on formaldehyde-fixed, paraffin-embedded muscle biopsy specimens. A glycohistochemical, immunohistochemical and glycobiochemical study
6. Galectins are diNerentially expressed in supratentorial pilocytic astrocytomas, astrocyto-mas, anaplastic astrocytomas and glioblastomas, and signifi-cantly modulate tumor astrocyte migration
7. Soluble galactose-binding vertebrate lectins: A family with common properties
8. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
9. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metallo-proteinases-3 to -9, retinoic acid receptor-β and antiapoptotic galectin-3
10. Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas
11. Kutane Lymphome
12. Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands
13. Animal lectins
14. Biological information transfer beyond the genetic code: The sugar code
15. Pattern of endogenous lectins in a human epithelial tumor
16. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas
17. Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody
18. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
19. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis
20. Detection of circulating T cells with CD4+CD7-immunophe-notype in patients with benign and malignant lymphoproliferative dermatoses
21. DiNerential gene expression profiles of scirrhous gastric cancer with high metastatic potential to peritoneum or lymph nodes
22. Recent topics on galectins
23. Human epidermal Langerhans cells are selectively recognized by galectin-3 but not galectin-1
24. Secretion of the galectin family of mammalian carbohydrate-binding proteins
25. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: Implications for apoptosis resistance and pathogenesis
26. Lectins as cell adhesion molecules
27. Mycosis fungoides: Expression of c-myc p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus
28. Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma
29. 1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture
30. Comprehensive galectin finger-printing in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures
31. Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis
32. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis
33. Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides
34. Galectin-8 expression decreases in cancer as compared to normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor
35. Detection of macrophage migration inhibitory factor by monoclonal antibody in Sezáry syndrome
36. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
37. Soluble lactose-binding lectin from rat intestine with two diNerent carbohydrate-binding domains in the same peptide chain
38. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death
39. Galectins: Versatile modulators of cell adhesion, cell proliferation and cell death
40. Galectins: An evolutionarily conserved family of animal lectins with multifunctional properties - A trip from the gene to clinical therapy
41. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezáry syndrome
42. Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer
43. Eukaryotic glycosylation: Whim of nature or multipurpose tool?
44. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase
45. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7-T helper lymphocytes expansion
46. Integrins α4β7 and αEβ7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis
47. Glycoproteins: Strucure and function
48. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides, and atopic dermatitis
49. Role of β1-integrins in epidermotropism of malignant T cells
50. Macrophage inhibitor factor (MIF) in cutaneous lymphoproliferative diseases
51. Biological roles of oligosaccharides: All of the theories are correct
52. Signaling pathways for transduction of the initial message of the glycocode into cellular responses
53. Two domains of rat galectin-4 bind to distinct structures of the intercellular borders of colorectal epithelia
54. Primary cutaneous lymphomas
55. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
56. The significance of glycosylated proteins
57. Sertoli cell expression of galectin-1 and -3 accessible binding sites in normal human testis and Sertoli cell only-syndrome
58. Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin
59. Pegylated doxorubicin for primary cutaneous T-cell lymphoma: A report on 10 patients with follow-up
60. Expression of galectin-3 modulates T-cell growth and apoptosis
61. Migration inhibitory activity in serum and cell supernatants patients with Sezàry syndrome
62. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): Association between lack of Fas expression and aggressive types of CTCL